TITLE

Atrophy: When too much atrophy is too little brain

AUTHOR(S)
Romanowski, Charles; Wilkinson, Iain
PUB. DATE
September 2011
SOURCE
Neuroradiology;Sep2011, Vol. 53, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses brain atrophy in the contexts of normal ageing and Alzheimer's disease (AD). The prevalence of AD and its possible connection with mild cognitive impairment (MCI) is mentioned. The discussion focuses on subtle changes that differentiate patients undergoing the normal process of brain ageing from those who have MCI or early AD.
ACCESSION #
64587689

 

Related Articles

  • Imaging Alzheimer in 2011. Hazewinkel, Marieke; Barkhof, Frederik // Neuroradiology;Sep2011, Vol. 53, p145 

    The article focuses on the use of diagnostic imaging in Alzheimer's Dementia (AD). Both magnetic resonance imaging (MRI) and computed tomography are sensitive enough to show medial temporal lobe atrophy and parietal atrophy. The proteins associated with AD, amyloid-beta and hyper-phosphorylated...

  • Multimodal Discrimination of Alzheimer’s Disease Based on Regional Cortical Atrophy and Hypometabolism. Yun, Hyuk Jin; Kwak, Kichang; Lee, Jong-Min; null, null // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Structural MR image (MRI) and 18F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) have been widely employed in diagnosis of both Alzheimer’s disease (AD) and mild cognitive impairment (MCI) pathology, which has led to the development of methods to distinguish AD and MCI from...

  • Subcortical volume changes in dementia with Lewy bodies and Alzheimer's disease. A comparison with healthy aging. Watson, Rosie; Colloby, Sean J.; Blamire, Andrew M.; O’Brien, John T.; O'Brien, John T // International Psychogeriatrics;Apr2016, Vol. 28 Issue 4, p529 

    Background: Differentiating Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), two of the commonest forms of dementia in older age, remains a diagnostic challenge. To assist with better understanding of the differences between the conditions during life, we assessed limbic and...

  • Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease. Trzepacz, Paula T.; Hochstetler, Helen; Yu, Peng; Castelluccio, Peter; Witte, Michael M.; Dell''agnello, Grazia; Degenhardt, Elisabeth K. // Dementia & Geriatric Cognitive Disorders;2016, Vol. 41 Issue 1/2, p68 

    Aims: To assess how hippocampal volume (HV) from volumetric magnetic resonance imaging (vMRI) is related to the amyloid status at different stages of Alzheimer's disease (AD) and its relevance to patient care. Methods: We evaluated the ability of HV to predict the florbetapir positron emission...

  • Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. Ferrari, Camilla; Nacmias, Benedetta; Bagnoli, Silvia; Piaceri, Irene; Lombardi, Gemma; Pradella, Silvia; Tedde, Andrea; Sorbi, Sandro // Neurodegenerative Diseases;Jan2014, Vol. 13 Issue 2/3, p157 

    There is strong evidence that Alzheimer's disease (AD) pathology starts decades before clinical onset. Cognitive reserve (CR) and brain reserve can be a good predictive model for AD development. Neuroimaging can help in describing cerebral reserves, as well as in detecting AD brain pathology...

  • Positron Emission Tomography Facilitates Diagnosis of Early-Onset Alzheimer’s Disease. McMurtray, Aaron M.; Licht, Eliot; Yeo, Tuty; Krisztal, Erica; Saul, Ronald E.; Mendez, Mario F. // European Neurology;2008, Vol. 59 Issue 1/2, p31 

    Background: Clinical positron emission tomography (PET) may help in the evaluation of presenile patients with memory complaints for the presence of Alzheimer’s disease (AD). Methods: Clinical PET scans from 27 patients with clinically probable AD and early ages of onset (<65 years) were...

  • Molecular Imaging in Sporadic Alzheimer's Disease Populations and Those Genetically at Risk. Nordberg, Agneta // Neurodegenerative Diseases;Jan2014, Vol. 13 Issue 2/3, p160 

    The time course and order of the pathological-physiological processes in Alzheimer's disease (AD) are still under investigation and it is expected that molecular imaging will provide important insight into early brain pathology. Multi-tracer positron emission tomography studies visualizing...

  • DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients. Jahng, Geon-Ho; Xu, Songfan; Weiner, Micheal; Meyerhoff, Dieter; Park, Seungjoon; Schuff, Norbert // Neuroradiology;Oct2011, Vol. 53 Issue 10, p749 

    Introduction: The objective of the study was to explore the impact of the background gradients on diffusion tensor (DT) magnetic resonance imaging (DT-MRI) in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), or cognitively normal (CN) aging. Methods: Two DT-MRI sets with...

  • Brain Functional Network in Alzheimer's Disease: Diagnostic Markers for Diagnosis and Monitoring. Rodriguez, Guido; Arnaldi, Dario; Picco, Agnese // International Journal of Alzheimer's Disease;2011, Vol. 2011, p1 

    Alzheimer's disease (AD) is the most common type of dementia that is clinically characterized by the presence of memory impairment and later by impairment in other cognitive domains. The clinical diagnosis is based on interviews with the patient and his/her relatives and on neuropsychological...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics